A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to investigate efficacy and safety of an herbal medicinal
product of (NW Low-Glu®) in patients with Type 2 Diabetes Mellitus (T2DM). The main
question[s] it aims to answer are:
• What will be the mean change in HbA1c levels in the experimental arm (NW Low-Glu®) compared
to the active-control arm (metformin) after 6 months of treatment?
Participants will randomized in a 1:1 allocation ratio, into one of the two treatment groups,
to receive either Metformin or NW Low-Glu®.
Researchers will compare the mean change in HbA1C, fasting blood glucose, and weight between
the experimental arm and the active-control arm.